ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000328.1|Coronatine_2 # 242 # 1090 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.564	BGC0000328.1|Coronatine_2 	242	1090	+	Loose	1250	25.0238	mecC	31.58	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGCACAGCCTGTTCACACTAAACCTGGACCTAGAGCGAGCCGGCAAGGTGATCTGTGCCCAGAGCTTGCCGTTCGACACTGCCCGGGAAACCCTCCTATTGTTATCGCCCGTGGGCACCCAGTGCTGCTACATGAAGAACGCTGCACTATTTCTGATCAGCCATTTCAATCTGATAATCCTGGAAAGCGACACCTGGCTGGCGTACGCCAACGAAGCCGGGGTCAATCCCGAAGAAGGCGTTGCGGACTTCATCCGCCAGTTCAATGCAGCGCTGCCAGAACCCGTGCGTGTAGATGCACTGGTGGGCTATTGCTCCTCAGCGCCTTTGGCACTCTTGGCAGCCAACCAAGGTGCTTGTCGCACCTTGCTACTGCTTAATGGCGCGTACTTTCTCAAAGACGACGGGGTGATCAAGAGCCAATACGAGCGCGACGTGGAGCGCATGATGCAGTCCATTCCCCAAGGCAATTGCGCCCAAGTCTACGAAGCCGTGAGTCTGTTGCACACCCAAAGCACCTATACCCCGAGTGACTATCGCTACCAGCAGGTTCGCCCTCTGCGAGAACTGTCTGCGTTCCGCCAGTACCTTACGTTCCTCAACAACCTGGCGAGCTTGGAATTGGTCAGAATTGCGCAGGCCGTAAAGACCCCCACGCTGGTGTGGTGCGGCAGCCAGGACCGTTATACCGACACCGCATCTTCCCGGTACATCGCCCAGCTGCTGCCTCACAGTGAACTGGTGGAAGATCCTGATGGCCAGCATCACGATTTTGTCGATGGCCACGAACGTTTGTACCTGACGATGACCCGTTTTCTGACCCGTCACAAGCAGAGGGCCATTCAATGA	MHSLFTLNLDLERAGKVICAQSLPFDTARETLLLLSPVGTQCCYMKNAALFLISHFNLIILESDTWLAYANEAGVNPEEGVADFIRQFNAALPEPVRVDALVGYCSSAPLALLAANQGACRTLLLLNGAYFLKDDGVIKSQYERDVERMMQSIPQGNCAQVYEAVSLLHTQSTYTPSDYRYQQVRPLRELSAFRQYLTFLNNLASLELVRIAQAVKTPTLVWCGSQDRYTDTASSRYIAQLLPHSELVEDPDGQHHDFVDGHERLYLTMTRFLTRHKQRAIQ	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	42.41	gnl|BL_ORD_ID|742|hsp_num:0	810			54	141	methicillin
BGC0000328.1|Coronatine_3 # 1087 # 2874 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.566	BGC0000328.1|Coronatine_3 	1087	2874	+	Loose	1000	113.235	almE	25.48	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCTCCTACCATTCACATCCTCCCAAAGCCTACCGCCGATTTGAGTCGGTCTGCACGCAAGCGCCAAACGCAATTGCGGTGGTGCACGAAGGAAAACCAGTCACTTATCAACAGCTCCAGACGCAGGTGTTGGAACGTAGCGAAGCACTGATACGTCAAGGCCTGGCAGACCATCCTTACATGCCGCTGATGGCCAACCGGTGCCTTGAGTATCTGATAACGATGCTGGCCTGCTGCAAACTGGGAATTACCTACGTCTCCATCGAGCCAAGCACGCCAAGCAAACGCCTGATCGCCGTGCTGGAACAATTGGGCTGCAATCATTTGCTATTGCTCGGTCAGCCAACGGACTTGCGCCCTGACCCAACGCTAACATGCTTTCGCCTGGACGACTGCGGCACTCTGTGCTCCGACGGCCCTGCCCTACGCCAGCCTATCCGACGGCGTCTGGATGATGCTTCGGTGATAACCGTGATGTTTACCTCTGGCACTACCGGCGTCCCCAAAGGTGTACGCATCAGCCAAGACGGGTTGCTGAATCTAGTAGACAACGTACAGCAACAGGTCCAAGGCAAGCCCCGCAGCTACGTACATCACTCGTCCATCGGCTTCGATGCTGCATTGTTTGAAGTGTGGGTACCGCTGCTGACAGGCGCCTGCGTCACCCTGCAACCTAGCGAGTTCAATATAGATGCACTGGATCACTGCGTACGCGCGGCCAGCTGCGATGTGCTGTTACTGACCACCTCACTGTTCCACCTGGTGGCGCAACACCGCCTTTCAATGCTCGAGGCTGTGCGCGTGCTCTATGTCGGCGGTGAAGTACTTAAACCGGTGCATGCCCGCGCGCTGCTGTTGGCCAATCCTCGCATTACCCTGGTGAATGGCTACGGCCCGACCGAGAATACAGTGTTCTCCACTTGGTACAGTTTGAACAAGCCTGAGGACGCCGAGCGAGACGTAATTCCTATCGGGCAGTTCCTACACCAGGTGCACGGCAAAATCGTCGATGCCAAACTGCAAGAGGTGGAGGTCGGCACGCCCGGCGAGTTGCTGCTCACAGGTGCGAATCTAGCCCTAGGTTACCTCGACGAAGCTTTGACCCCAACCCGCTTTCTACAACTGCCGGAAGGCACCTATTACCGGACCGGCGACTATGTCATCCAAGATGAGCACGGCATGCTTTTCTACCAAGGCCGCATTGACGAACAGGTAAAAATCAAAGGCTTCCGGGTGGAGATCGCCGAGGTCGAACATGCGCTGACCCAACTGCCTGGCGTCGCCCAGGCTGTGGTGCAGGCGCATGTCATGAACGATTTGGAAAACAGCCTACACGCTTTCATCGTGTTCCGGCATGGCTCGCCAACTATCGAAGAAAGCAAGCTCATGAGCCTATTGGGCGACCGGCTTCCTCATTACATGGTACCGAGGCGGATCCACTACCTGGCGGAACTTCCGCTGACGGCCAATGGCAAAGTCGACAAGCGTTCCTTACAGCCGCCGGAGAAAGCAGCGGTGGTGTCCCCTCAGGCCGGTTCGGCAGTGCTAGAGATCTGGTCCGGCATCCTCGGCACCCGCAACCTGCAGTTGGAACACTCAATTTACGGCTATGGCGCCTCATCTTTGAGCGTGGTCATGGCCCATAGCCGCATCAACGAAATACTTGGCAGAACGACCCCTTTCGACGAAGTCGCCAGGCTGAGCACCTTTCAAGAGTGGGTGCAGTACTACGCAACGCATGCAGACCCAGTAACTTCTCTCAGGAGCCAACATGGAAATCACTGA	MTSYHSHPPKAYRRFESVCTQAPNAIAVVHEGKPVTYQQLQTQVLERSEALIRQGLADHPYMPLMANRCLEYLITMLACCKLGITYVSIEPSTPSKRLIAVLEQLGCNHLLLLGQPTDLRPDPTLTCFRLDDCGTLCSDGPALRQPIRRRLDDASVITVMFTSGTTGVPKGVRISQDGLLNLVDNVQQQVQGKPRSYVHHSSIGFDAALFEVWVPLLTGACVTLQPSEFNIDALDHCVRAASCDVLLLTTSLFHLVAQHRLSMLEAVRVLYVGGEVLKPVHARALLLANPRITLVNGYGPTENTVFSTWYSLNKPEDAERDVIPIGQFLHQVHGKIVDAKLQEVEVGTPGELLLTGANLALGYLDEALTPTRFLQLPEGTYYRTGDYVIQDEHGMLFYQGRIDEQVKIKGFRVEIAEVEHALTQLPGVAQAVVQAHVMNDLENSLHAFIVFRHGSPTIEESKLMSLLGDRLPHYMVPRRIHYLAELPLTANGKVDKRSLQPPEKAAVVSPQAGSAVLEIWSGILGTRNLQLEHSIYGYGASSLSVVMAHSRINEILGRTTPFDEVARLSTFQEWVQYYATHADPVTSLRSQHGNH	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.01	gnl|BL_ORD_ID|4935|hsp_num:0	5928			132	1632	colistin A; colistin B
BGC0000328.1|Coronatine_4 # 2861 # 3790 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.549	BGC0000328.1|Coronatine_4 	2861	3790	+	Loose	700	25.0238	adeS	23.53	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAATCACTGACTTTTCGTTGACGAAACAGGAACTTCAGCAATTTGATCGAGATGGGTTCATCGGTCCCTTCACGCTCTATGAGCCTGAAGAGATGAAACAGATGCATAAGACCATCCGAGCACAACTGTTCAACCGCACCCATGCTCCCTACGACGCGCCACTGGATGTCGCGATCACCAACTACGACCGGCACCTGGATGTGGACTTGCTGACCAGTCATGTGTTTCGCAAGGAAATCGTGCATCGAGTGCGAAGCATCCTCGGCCCGGATGTAATCTGCTGGCGCAGCGAGTTCATCCCCAAATACCCAGGCAACGAAGGCACTGACTGGCACCAGGCAGACACTTTCGCTCACGCCTCCGGCGAGCCGCAACTGGTGTGGCCCGAGGGCGAGCCGTTCGGCGGCGCTATTAATGTGTGGACGGGTTTCACTGATGCCTCCCAAGAAAACGGCTGCATGCAGTTCATCCCCGGCAGCCACAAGCAAATGAACTACGACGAAACCAGGGGCATGACCTTCGACCCGGTCACCAACAATAATGTGGTCAAGGGGCAGTATGCACGTGGATTCAACGGCTACGACTACACCACTCTGCAAAAGGACAAGTCATGGAAGCCGGATGAAGCTTCGGCAGTACCGATCGTGATGAAAGCGGGCCAATTTGTAATCTTCCGCTCGATGCTTATGCACTCCTCGCTACCCAATTCGACAACCGACAAGACCCGCCTGGGCTATGTGGCCCGCTACGTACCCGGACGGGTCAAGGTTTATCCAGATACAGATTACGTTAAGGAATTCGGGGGCGAGTATCGACTTGATCGGTTCGGCGTGGTGCAGGTGGCCGGTACCACCACCGACCCCAAGAACAAAGTGGCCATCAAGAGCCTAAGCGGCATGGACCTGAAGCCCCTAGTCATTTATTGA	MEITDFSLTKQELQQFDRDGFIGPFTLYEPEEMKQMHKTIRAQLFNRTHAPYDAPLDVAITNYDRHLDVDLLTSHVFRKEIVHRVRSILGPDVICWRSEFIPKYPGNEGTDWHQADTFAHASGEPQLVWPEGEPFGGAINVWTGFTDASQENGCMQFIPGSHKQMNYDETRGMTFDPVTNNNVVKGQYARGFNGYDYTTLQKDKSWKPDEASAVPIVMKAGQFVIFRSMLMHSSLPNSTTDKTRLGYVARYVPGRVKVYPDTDYVKEFGGEYRLDRFGVVQVAGTTTDPKNKVAIKSLSGMDLKPLVIY	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	85.60	gnl|BL_ORD_ID|166|hsp_num:0	183			255	459	tigecycline; tetracycline
BGC0000328.1|Coronatine_5 # 3800 # 4222 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.570	BGC0000328.1|Coronatine_5 	3800	4222	+	Loose	200	23.483	BLMT	36.36	3005036	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic inactivation	Bleomycin resistant protein	ATGGAACAGCCCTCCTACCTGGCAATCGATCACATCGCGTATGCCACGCGGTCTACGGAGAAAACCTCGGCGTTCTTCACGGCCTTGGGGTTCGAGGTGCTGTTCCATAAACAACCCATCGAAAAGTTTGGCGTGTTGATAACCAAGCTCCGCTCGCCAGCAGGCGAAATCGTGGAAGTGGTCGAACCCTTTCGACCTGACAGCGTGGTCAGCCGGCTGCTGGTGAATGTGGAGGCGTGTATATACCATGCGGCCTTTAGGGTCCGCGATATCCAGACTACTCAGACGTCTCTGGCCAGTATCGGAGGCGTCTCGGTAACCAAACCCATGACCATTCCGTACCCGGCCACCGAGGAACATCGCTCGCTGACAACCTCGCACATGTTCCACCCCGCAGTGGGCCTGTTCGAGATCACCGGTTAA	MEQPSYLAIDHIAYATRSTEKTSAFFTALGFEVLFHKQPIEKFGVLITKLRSPAGEIVEVVEPFRPDSVVSRLLVNVEACIYHAAFRVRDIQTTQTSLASIGGVSVTKPMTIPYPATEEHRSLTTSHMFHPAVGLFEITG	MTDQATPNLPSRDFDSTAAFYERLGFGIVFRDAGWMILQRGDLMLEFFAHPGLDPLASWFSCCLRLDDLAEFYRQCKSVGIQETSSGYPRIHAPELQEWGGTMAALVDPDGTLLRLIQNELLAGIS	111.11	gnl|BL_ORD_ID|2776|hsp_num:0	3789			30	96	bleomycin
BGC0000328.1|Coronatine_6 # 4232 # 4993 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.587	BGC0000328.1|Coronatine_6 	4232	4993	+	Loose	200	28.4906	vanH gene in vanF cluster	32.5	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGGCCGATCCTTTTGTGGTGCAACGGCCCTGGCTTGCACCACTGCCAGGCGCCCCTATGAACGCATGTCGCCTGCTGCTGTGTTTCCCCTACGGAGGAGGTGGCGCCTCAGCGTTCAATGGTTTGAGCCGGCTAGCCGAGGTCGGCGTTGCGACATGGGCAGTGAAACTACCTGGACGCGAGGATCGAAGTATGGAAGCGCCGGTCACGCGGGTCGCGCATGTTATCGAGGCGATCCTCGATGCACTGCAAAGCGTAGGCATGCCGTACGCGTTTTACGGTCACAGCTTCGGTGCCGGGTTGGCGCTTGATGTAACCCACGCGCTAGTCGAACGCGACCGGCCGCTGCCGACGAATTTGGTCCTGTCCGGGCGCATGCCGCCCCATACCGGCTACTCACCGCTACTGGGTGCGATGGACGACAACCAATTGTGGCAGCACGTATGCTCAGAGAGCCTCTTGCCACTGCCGACGGATGCCTCGTGCAGTTTCGCCAGGCATGCGCTGGGCAAGCTCAAAGCCGACCTAGCGCTCAATGCACAACTCACTTATCGCTTTATCCGGCCGCTGCCAGTGCCCCTTTACGTTCTCAACGGCCAGGACGACCCGTTGCTTGAGCTCCATCGCCTAGACGAATGGCAGCGCTACACCAGCAAAAGCTTCCATAGCGAGTACGTACCCGGCGGACATTTTTTCTTCAACATCAATTTTCAGCTTTTGTACTTGCCTCTGTTAACCGCTCTAGATGAACAAGGCAGTTGA	MADPFVVQRPWLAPLPGAPMNACRLLLCFPYGGGGASAFNGLSRLAEVGVATWAVKLPGREDRSMEAPVTRVAHVIEAILDALQSVGMPYAFYGHSFGAGLALDVTHALVERDRPLPTNLVLSGRMPPHTGYSPLLGAMDDNQLWQHVCSESLLPLPTDASCSFARHALGKLKADLALNAQLTYRFIRPLPVPLYVLNGQDDPLLELHRLDEWQRYTSKSFHSEYVPGGHFFFNINFQLLYLPLLTALDEQGS	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	78.57	gnl|BL_ORD_ID|1652|hsp_num:0	1790			414	534	vancomycin
BGC0000328.1|Coronatine_7 # 4999 # 5235 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.536	BGC0000328.1|Coronatine_7 	4999	5235	+	Loose	500	22.3274	apmA	41.18	3003918	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGGAACGTGTATTTTGGAACACCCCTTATCTTTCGTCCCTAGACGCTTGCGTGCTAAGTATTGACGGGCTCGACGTGGTGATCAGCCCGACGATTTTCTTCGCCGAATACGGCGGCCAAGAATCGGATAAGGGTTGCATCAACCGTATCGAAGTCACCCAGGCCACGGTTGTTGACGAGCGCATCATCTATCGGCCTTGCCGAAGATCCAGACTTTGCCGTGGGCGATCTGGTTAG	MERVFWNTPYLSSLDACVLSIDGLDVVISPTIFFAEYGGQESDKGCINRIEVTQATVVDERIIYRPCRRSRLCRGRSG	MKTRLEQVLERYLNGREVAVWGVPTRRLLRALKPFKFHTADRVDPQYHYVVAVTDDDLTDFLSDEQSKSFQYANDYLTFDDEGGELPFERMCFNVPVGRQTYFGDGVVGACENGYIKSIGQFTSINGTAEIHANHQLNMTFVSDDIQNFFNEESMAVFQEKLRKDPKHPYAYSKEPMTIGSDVYIGAHAFINASTVTSIGDGAIIGSGAVVLENVPPFAVVVGVPARIKRYRFSKEMIETLLRVKWWDWSIEEINENVDALISPELFMKKYGSL	28.47	gnl|BL_ORD_ID|2163|hsp_num:0	2395			765	816	apramycin
BGC0000328.1|Coronatine_8 # 5643 # 6254 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.523	BGC0000328.1|Coronatine_8 	5643	6254	+	Loose	800	24.6386	adeI	22.68	3000780	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTCAACATCATGTCTGTACTTGGGTTGCTGCTCTTGATGCCAGGGCCAACGAATACATTGCTGCTGCGGTCTGGAGCACTGAGCGGATTCCGACACGCCTGGTCTTTGAGCCTGCTGGAATACTCGGCCTACCTGCTGCAGATTTCCTTTTGGGGGTATCTGCTCAGACATATCGGTGACAGCGCTCCCTGGTGCCTCAAGGTGGTACAACTGGCGTCGATGGCTTATCTGTTCAAAACCTCACACCGGCTATGGCGCAACCCCGATAACCCTTGCCATTCCTCACCCAACGTGCAGATATCCGGAATGTACTTTTTTCGGCTGACCCTGATCAACCCCAAGGGTCTACTGGTGGTTTCGTTCATCGCTCCCGAGCAGACCTTTACCGATATCAAGTTGTACCTGTATTTTGTCGCGCAACTCAGTATGGTGGTAATCCCGATTGGCTGTGCCTGGGTGCTGCTTGGCGCATACATCAAACGCAGCGGGCATGCTTGGCTGACAACGCTGAATATTAATCGCACAGCCTCGGTGATCATTTGCTGCTTCGCGGTGGCGATCCTTTCCCAATTGACTGACTCACTGATCAAGACCAAATTGGCATTTTAG	MFNIMSVLGLLLLMPGPTNTLLLRSGALSGFRHAWSLSLLEYSAYLLQISFWGYLLRHIGDSAPWCLKVVQLASMAYLFKTSHRLWRNPDNPCHSSPNVQISGMYFFRLTLINPKGLLVVSFIAPEQTFTDIKLYLYFVAQLSMVVIPIGCAWVLLGAYIKRSGHAWLTTLNINRTASVIICCFAVAILSQLTDSLIKTKLAF	MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSVELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQQQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYSTIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGSLNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTAQIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKAGDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA	48.80	gnl|BL_ORD_ID|1347|hsp_num:0	1471			819	1110	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
